The value of oxygen-carrying solutions in the operative setting, as determined by mathematical modeling

Transfusion

Volumn 39, Issue 4, 1999, Pages 396-402

  Brecher, Mark E ^a   Goodnough, Lawrence T ^b   Monk, Terri ^c  

^a UNIVERSITY OF NORTH CAROLINA HOSPITALS   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLEEDING; BLOOD TRANSFUSION; BLOOD VOLUME; ERYTHROCYTE TRANSFUSION; HEMATOCRIT; HUMAN; MATHEMATICAL MODEL; OXYGEN TRANSPORT;

EID: 0032931640     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1999.39499235673.x     Document Type: Article

References (15)

1. Marwick C. More than a trickle of interest in blood substitutes. JAMA 1994;271:895.
2. Dracker RA, Beadling W, Lauenstien K. The search for a clinically useful blood substitute. Lab Med 1994;25:720-3.
3. Bakker JC, Bleeker WK. Blood substitutes based on modified hemoglobin. Vox Sang 1994;67:139-42.
4. Scott MG, Kucik DF, Goodnough LT, Monk TG. Blood substitutes: evolution and future applications. Clin Chem 1997;43:1724-31.
5. Gould SA, Sehgal LR, Sehgal HR, Moss GS. The role of hemoglobin solutions in massive transfusion. In: Jefferies LC, Brecher ME, eds. Massive transfusion. Bethesda: American Association of Blood Banks, 1994:43-64.
6. Glick MR, Ryder KW. Double trouble: hemolysis and stabilized hemoglobins (so you think you're seeing red now?). Clin Chem 1993;39:1761-3.
7. Ma Z, Monk TG, Goodnough LT, et al. Effect of hemoglobin- and Perflubron-based oxygen carriers on common clinical laboratory tests. Clin Chem 1997;43:1732-7.
8. Viele MK, Weiskopf RB, Fisher D. Recombinant human hemoglobin does not affect renal function in humans: analysis of safety and pharmocokinetics. Anesthesiology 1997;86:848-58.
9. Brecher ME, Rosenfeld M. Mathematical and computer modeling of acute normovolemic hemodilution. Transfusion 1994;34:176-9.
10. Weiskopf RB. Mathematical analysis of isovolemic hemodilution indicates that it can decrease the need for allogeneic blood transfusion. Transfusion 1995;35:37-41.
11. Cohen IA, Brecher ME. Preoperative autologous blood donation: benefit or detriment? A mathematical analysis. Transfusion 1995;35:640-4; erratum appears Transfusion 1996;36:1036.
12. Brecher ME, Goodnough LT, Monk T. Where does preoperative erythropoietin therapy count? A mathematical perspective. Transfusion 1999;39:392-5.
13. Bourke DL, Smith TC. Estimating allowable hemodilution. Anesthesiology 1974;41:609-12.
14. Goodnough LT, Brecher ME, Monk TG. Acute normovolemic hemodilution in surgery. Hematology 1997;2:413-20.
15. Goodnough LT, Bravo JR, Hsueh Y, et al. Red blood cell mass in autologous and homologous blood units. Implications for risk/benefit assessment of autologous blood crossover and directed blood transfusion. Transfusion 1989;29:821-2.